MediGene
Advent contact Kaasim Mahmood
Company CEO Dr. Frank Mathias
Anti-cancer drugs
Anti-cancer drugs
MediGene (XETRA: MDG) focuses on two therapeutic areas: cancer and autoimmune diseases. MediGene is the first German biotech company with drugs on the market and also has several drug candidates in clinical development. Licensed products complement the proprietary drug portfolio.
- Follow MediGene
- medigene.de